Comparative in vitro effects of novel and conventional parasiticides on Thaparocleidus vistulensis (Siwak, 1932) (Monopisthocotyla) parasitizing European catfish (Silurus glanis)
Wan Muhammad Hazim Wan Sajiri , Csaba Székely , István Czeglédi , Kurt Buchmann , Boglárka Sellyei
{"title":"Comparative in vitro effects of novel and conventional parasiticides on Thaparocleidus vistulensis (Siwak, 1932) (Monopisthocotyla) parasitizing European catfish (Silurus glanis)","authors":"Wan Muhammad Hazim Wan Sajiri , Csaba Székely , István Czeglédi , Kurt Buchmann , Boglárka Sellyei","doi":"10.1016/j.aqrep.2025.102952","DOIUrl":null,"url":null,"abstract":"<div><div>This <em>in vitro</em> study compares the effects of the novel biological parasiticide Biokos (BIO) to the conventional anthelmintics Praziquantel (PZQ) and Mebendazole (MBZ) on the gill parasitic monopisthocotylan <em>Thaparocleidus vistulensis</em> (Siwak, 1932), a species-specific parasite of European catfish (<em>Silurus glanis</em>). Parasites were exposed to long-term treatment and tested at concentrations of 0, 1, 5, 10, 20, 40, 60, 80, and 100 mg/L. The antiparasitic effects were observed at all life cycle stages, including eggs, oncomiracidia, developing juvenile, and adult monopisthocotylans. <em>In vitro</em> assays demonstrated MBZ to be the most effective in inhibiting the development of eggs with 100 % efficacy. Treatment of BIO was proven effective in targeting the oncomiracidia life stage compared to the others. Higher concentrations are required for all antiparasitic treatments to show their effectiveness against developing juvenile and adult <em>T. vistulensis</em>. This suggests that strategic combinations of the parasiticides may elevate efficacy.</div></div>","PeriodicalId":8103,"journal":{"name":"Aquaculture Reports","volume":"43 ","pages":"Article 102952"},"PeriodicalIF":3.2000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aquaculture Reports","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352513425003382","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"FISHERIES","Score":null,"Total":0}
引用次数: 0
Abstract
This in vitro study compares the effects of the novel biological parasiticide Biokos (BIO) to the conventional anthelmintics Praziquantel (PZQ) and Mebendazole (MBZ) on the gill parasitic monopisthocotylan Thaparocleidus vistulensis (Siwak, 1932), a species-specific parasite of European catfish (Silurus glanis). Parasites were exposed to long-term treatment and tested at concentrations of 0, 1, 5, 10, 20, 40, 60, 80, and 100 mg/L. The antiparasitic effects were observed at all life cycle stages, including eggs, oncomiracidia, developing juvenile, and adult monopisthocotylans. In vitro assays demonstrated MBZ to be the most effective in inhibiting the development of eggs with 100 % efficacy. Treatment of BIO was proven effective in targeting the oncomiracidia life stage compared to the others. Higher concentrations are required for all antiparasitic treatments to show their effectiveness against developing juvenile and adult T. vistulensis. This suggests that strategic combinations of the parasiticides may elevate efficacy.
Aquaculture ReportsAgricultural and Biological Sciences-Animal Science and Zoology
CiteScore
5.90
自引率
8.10%
发文量
469
审稿时长
77 days
期刊介绍:
Aquaculture Reports will publish original research papers and reviews documenting outstanding science with a regional context and focus, answering the need for high quality information on novel species, systems and regions in emerging areas of aquaculture research and development, such as integrated multi-trophic aquaculture, urban aquaculture, ornamental, unfed aquaculture, offshore aquaculture and others. Papers having industry research as priority and encompassing product development research or current industry practice are encouraged.